ABCB Stock Analysis: Ameris Bancorp | NYSE
Banks - Regional | NYSE, USA | Market Cap: 5.543m USD | 12M Return: 13.2% | US03076K1088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 32.6M
EPS Trend: 99.1%
Qual. Beats: 0
Rev. Trend: 92.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Ameris Bancorp (NYSE: ABCB) is a U.S. bank holding company headquartered in Atlanta, Georgia, founded in 1971 and publicly traded since 1994. Operating primarily through its subsidiary Ameris Bank, the company serves retail and commercial customers across four business segments: Banking, Retail Mortgage, Warehouse Lending, and Premium Finance. Its deposit products span commercial and retail checking, savings, money market, IRA, and certificate of deposit accounts, while its lending activities include commercial and residential real estate, agricultural, commercial and industrial, consumer, equipment finance, SBA, and commercial insurance premium loans. The company distributes these services through full-service domestic banking offices and mortgage and loan production offices.
As a regional bank, Ameris operates within the U.S. Financials sector, where holding companies are regulated at the federal level by the Federal Reserve and benefit from a diversified fee-income mix. Two of its more specialized segments reflect niche banking models: warehouse lending provides short-term, collateralized funding to mortgage originators awaiting loan sale or securitization, while premium finance involves lending against commercial insurance premiums as an alternative to traditional premium financing channels.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan losses pressure credit costs
- Premium Finance Division growth boosts noninterest income
| Net Income: 386.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.77 > 1.0 |
| NWC/Revenue: -19.01% < 20% (prev -1.17k%; Δ 1.15k% < -1%) |
| CFO/TA 0.02 > 3% & CFO 663.7m > Net Income 386.4m |
| Net Debt (852.7m) to EBITDA (527.9m): 1.62 < 3 |
| Current Ratio: 0.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (67.0m) vs 12m ago -2.39% < -2% |
| Gross Margin: 70.51% > 18% (prev 67.42%; Δ 3.09% > 0.5%) |
| Asset Turnover: 6.13% > 50% (prev 6.00%; Δ 0.13% > 0%) |
| Interest Coverage Ratio: 1.11 > 6 (EBIT TTM 498.4m / Interest Expense TTM 450.1m) |
| A: -0.01 (Total Current Assets 211.1m - Total Current Liabilities 535.2m) / Total Assets 28.5b |
| B: 0.09 (Retained Earnings 2.45b / Total Assets 28.5b) |
| C: 0.02 (EBIT TTM 498.4m / Avg Total Assets 27.8b) |
| D: 0.17 (Book Value of Equity 4.12b / Total Liabilities 24.4b) |
| Altman-Z'' = 0.50 = B |
As of November 20, 2026, the stock is trading at USD 80.65 with a total of 481,640 shares traded. Over the past week, the price has changed by -2.24%, over one month by +1.79%, over three months by -6.80% and over the past year by +13.20%.
Current recommended Stop Loss: 76.10 (which is 5.6% or 2.7 ATR below the current price).
Ameris Bancorp has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold ABCB.
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 93 | 15.3% |
P/E Trailing = 14.4598
P/E Forward = 13.0039
P/S = 4.6152
P/B = 1.3462
P/EG = 1.1019
Revenue TTM = 1.71b USD
EBIT TTM = 498.4m USD
EBITDA TTM = 527.9m USD
Long Term Debt = 1.06b USD (from longTermDebt, last quarter)
Short Term Debt = 535.2m USD (from shortTermDebt, last fiscal year)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 852.7m USD (calculated: Debt 1.06b - CCE 211.1m)
Enterprise Value = 6.40b USD (5.54b + Debt 1.06b - CCE 211.1m)
Interest Coverage Ratio = 1.11 (Ebit TTM 498.4m / Interest Expense TTM 450.1m)
EV/FCF = 10.07x (Enterprise Value 6.40b / FCF TTM 635.2m)
FCF Yield = 9.93% (FCF TTM 635.2m / Enterprise Value 6.40b)
FCF Margin = 37.25% (FCF TTM 635.2m / Revenue TTM 1.71b)
Net Margin = 22.66% (Net Income TTM 386.4m / Revenue TTM 1.71b)
Gross Margin = 70.51% ((Revenue TTM 1.71b - Cost of Revenue TTM 502.8m) / Revenue TTM)
Gross Margin QoQ = 70.01% (prev 69.82%)
Tobins Q-Ratio = 0.22 (Enterprise Value 6.40b / Total Assets 28.5b)
Interest Expense / Debt = 42.31% (Interest Expense 450.1m / Debt 1.06b)
Taxrate = 22.47% (112.0m / 498.4m)
NOPAT = 386.4m (EBIT 498.4m * (1 - 22.47%))
Current Ratio = 0.39 (Total Current Assets 211.1m / Total Current Liabilities 535.2m)
Debt / Equity = 0.26 (Debt 1.06b / totalStockholderEquity, last quarter 4.12b)
Debt / EBITDA = 1.62 (Net Debt 852.7m / EBITDA 527.9m)
Debt / FCF = 1.34 (Net Debt 852.7m / FCF TTM 635.2m)
Total Stockholder Equity = 4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 386.4m / Total Assets 28.5b)
RoE = 9.44% (Net Income TTM 386.4m / Total Stockholder Equity 4.09b)
RoCE = 9.66% (EBIT 498.4m / Capital Employed (Equity 4.09b + L.T.Debt 1.06b))
RoIC = 1.36% (NOPAT 386.4m / Invested Capital 28.5b)
WACC = 12.24% (E(5.54b)/V(6.61b) * Re(8.30%) + D(1.06b)/V(6.61b) * Rd(42.31%) * (1-Tc(0.22)))
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.48 | Cagr: -1.29%
[DCF] Terminal Value 66.44% ; FCFF base≈539.0m ; Y1≈617.8m ; Y5≈909.3m
[DCF] Fair Price = 107.8 (EV 8.08b - Net Debt 852.7m = Equity 7.23b / Shares 67.0m; r=12.24% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.09 | EPS CAGR: 20.19% | SUE: 0.50 | # QB: 0
Revenue Correlation: 92.58 | Revenue CAGR: 4.16% | SUE: 0.59 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.65 | Chg30d=-0.18% | Revisions=-50% | Analysts=7
EPS current Year (2026-12-31): EPS=6.67 | Chg30d=+0.69% | Revisions=+44% | GrowthEPS=+11.4% | GrowthRev=+5.9%
EPS next Year (2027-12-31): EPS=7.04 | Chg30d=+0.12% | Revisions=-22% | GrowthEPS=+5.5% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: -6% (up=7, down=8)